Evidence map›Paper›PMID 33216797›Full record

ArticlePLoS pathogens2020

Calcineurin phosphatase activity regulates Varicella-Zoster Virus induced cell-cell fusion.

Momei Zhou, Vivek Kamarshi, Ann M Arvin, Stefan L Oliver

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. The Structures and Functions of VZV Glycoproteins.Current topics in microbiology and immunology · 2023
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Momei ZhouDepartment of Pediatrics, Stanford University School of Medicine, Stanford, California, United States of America.ORCID 0000-0002-9063-6760
Vivek KamarshiDepartment of Pediatrics, Stanford University School of Medicine, Stanford, California, United States of America.ORCID 0000-0003-0297-926X
Ann M ArvinDepartment of Pediatrics, Stanford University School of Medicine, Stanford, California, United States of America.ORCID 0000-0001-5404-1498
Stefan L OliverDepartment of Pediatrics, Stanford University School of Medicine, Stanford, California, United States of America.
Stanford University · US

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Vittorio Sebastiano · 2007 to 2026
$71.4M
Varicella-Zoster Virus: T Cell/Skin Tropisms &ImmunityR01AI020459 · NIAID · STANFORD UNIVERSITY · PI OLIVER, STEFAN LYNE · 1985 to 2023
$6.4M
Varicella-Zoster Virus: T Cell/Skin Tropisms & ImmunityR37AI020459 · NIAID · STANFORD UNIVERSITY · PI ARVIN, ANN · 2016 to 2020
$2.0M
Varicella zoster virus: molecular controls of cell fusion-dependent pathogenesisR01AI102546 · NIAID · STANFORD UNIVERSITY · PI ARVIN, ANN · 2012 to 2016
$1.9M
NCI NIH HHS P30 CA124435NIAID NIH HHS R01 AI020459NIAID NIH HHS R01 AI102546
6 · The paper itself

Abstract

Cell-cell fusion (abbreviated as cell fusion) is a characteristic pathology of medically important viruses, including varicella-zoster virus (VZV), the causative agent of chickenpox and shingles. Cell fusion is mediated by a complex of VZV glycoproteins, gB and gH-gL, and must be tightly regulated to enable skin pathogenesis based on studies with gB and gH hyperfusogenic VZV mutants. Although the function of gB and gH-gL in the regulation of cell fusion has been explored, whether host factors are directly involved in this regulation process is unknown. Here, we discovered host factors that modulated VZV gB/gH-gL mediated cell fusion via high-throughput screening of bioactive compounds with known cellular targets. Two structurally related non-antibiotic macrolides, tacrolimus and pimecrolimus, both significantly increased VZV gB/gH-gL mediated cell fusion. These compounds form a drug-protein complex with FKBP1A, which binds to calcineurin and specifically inhibits calcineurin phosphatase activity. Inhibition of calcineurin phosphatase activity also enhanced both herpes simplex virus-1 fusion complex and syncytin-1 mediated cell fusion, indicating a broad role of calcineurin in modulating this process. To characterize the role of calcineurin phosphatase activity in VZV gB/gH-gL mediated fusion, a series of biochemical, biological and infectivity assays was performed. Pimecrolimus-induced, enhanced cell fusion was significantly reduced by shRNA knockdown of FKBP1A, further supporting the role of calcineurin phosphatase activity in fusion regulation. Importantly, inhibition of calcineurin phosphatase activity during VZV infection caused exaggerated syncytia formation and suppressed virus propagation, which was consistent with the previously reported phenotypes of gB and gH hyperfusogenic VZV mutants. Seven host cell proteins that remained uniquely phosphorylated when calcineurin phosphatase activity was inhibited were identified as potential downstream factors involved in fusion regulation. These findings demonstrate that calcineurin is a critical host cell factor pivotal in the regulation of VZV induced cell fusion, which is essential for VZV pathogenesis.

Indexed as

CalcineurinCell FusionCell LineChickenpoxGlycoproteinsHerpesvirus 3, HumanHerpes ZosterHumansMembrane GlycoproteinsMutationPhosphoric Monoester HydrolasesViral Envelope ProteinsViral ProteinsCalcineurincalcineurin phosphataseglycoprotein B, varicella-zoster virusGlycoproteinsgp 118 protein, Herpesvirus 3, HumanMembrane GlycoproteinsPhosphoric Monoester HydrolasesViral Envelope ProteinsViral Proteins

Identifiers

PMID33216797
PMCPMC7717522
OpenAlexW3098749776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.